BenQ Medical Technology (4116) — Cash Flow-to-Debt Ratio
BenQ Medical Technology (4116) has a Cash Flow-to-Debt Ratio of 0.06x as of June 2025, meaning its operating cash flow of NT$179.07 Million could theoretically repay 0% of its total liabilities (NT$3.14 Billion) in one year. See BenQ Medical Technology (4116) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BenQ Medical Technology Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for BenQ Medical Technology across 8 annual periods. Also explore net asset growth rate of BenQ Medical Technology to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BenQ Medical Technology (2017–2024)
Year-by-year debt coverage analysis for BenQ Medical Technology. For market capitalisation and broader financial context, see how much is BenQ Medical Technology worth.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | NT$222.22 Million | NT$2.97 Billion | ▼ -57.2% |
| 2023 | 0.17x | NT$442.35 Million | NT$2.53 Billion | ▼ -23.4% |
| 2022 | 0.23x | NT$378.77 Million | NT$1.66 Billion | ▲ +60.7% |
| 2021 | 0.14x | NT$121.35 Million | NT$855.51 Million | ▼ -36.5% |
| 2020 | 0.22x | NT$151.48 Million | NT$677.80 Million | ▼ -22.7% |
| 2019 | 0.29x | NT$169.23 Million | NT$585.25 Million | ▲ +35.1% |
| 2018 | 0.21x | NT$126.10 Million | NT$589.30 Million | ▲ +39.5% |
| 2017 | 0.15x | NT$72.97 Million | NT$475.80 Million | — |